Abstract
therapy (pancytopenia), but after omission the patient settled into the original condition. 28 patients of the 32 achieved remission after the second infusion of cyclophosphamide. Conclusion: Remission was maintained in all patients for 9 months on he average (mostly by CD patients) and the drug was well tolerated. Our experience suggest that intravenous pulse cyclophosphamide therapy may be a safe and effective treatment for patients with severe IBD unresponsive for conventional treatment, but further controlled study should be considered in the future in more diverse patient population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
